CIK 0001385818
- Non-accelerated filer
- Smaller reporting company
AYTU BIOPHARMA, INC
Sign in to watch- Ticker
- AYTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 470883144
- Phone
- +1 720-437-6580
- Business address
- 7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
- Former names
- AYTU BIOSCIENCE, INC, Rosewind CORP
- 4 Open-market buy Chief Financial Officer bought 66,600 shares at $0.45 ($29,970)
- 4 Open-market buy Chief Operating Officer bought 226,105 shares at $0.45 ($101,747)
- 4 Grant or award Chief Financial Officer acquired 75,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 150,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 1,666,667 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 1,666,667 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Exercise or conversion Director acquired 37,083 shares (option exercise)
Page 7 of 10 · 187 filings